These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1478154)

  • 1. Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans.
    Okuda Y; Mizutami M; Tanaka K; Isaka M; Yamashita K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):139-40. PubMed ID: 1478154
    [No Abstract]   [Full Text] [Related]  

  • 2. Iloprost and peripheral arterial disease in diabetic patients.
    Vicari AM; Chiesa R; Mari G; Galimberti M; Di Carlo V; Pozza G
    Acta Diabetol Lat; 1991; 28(1):113-4. PubMed ID: 1713729
    [No Abstract]   [Full Text] [Related]  

  • 3. [Functional state of regional hemodynamics in patients with diabetes mellitus and arteriosclerosis obliterans of the lower extremities].
    Zubkova ST
    Klin Khir (1962); 1987; (7):19-21. PubMed ID: 3656952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).
    Nomura S; Taniura T; Shouzu A; Omoto S; Suzuki M; Okuda Y; Ito T
    Vasc Health Risk Manag; 2018; 14():225-232. PubMed ID: 30271161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regional hemodynamics in diabetes mellitus patients with atherosclerotic vascular occlusions of the lower extremities].
    Bakharev AM; Nikul'nikov PI
    Klin Khir (1962); 1981 Mar; (3):38-40. PubMed ID: 7218705
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the therapy of peripheral arteriosclerosis obliterans].
    Pupita F; Stefanelli G
    Minerva Cardioangiol; 1968 Nov; 16(11):1083-93. PubMed ID: 5707453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intra-arterial administration of pyrrolidin-methyl-tetracycline in the treatment of various obliterative angiopathies].
    Del Corso P; Zeme D; Beverelli M
    Clin Ter; 1970 Nov; 55(3):231-8. PubMed ID: 5516887
    [No Abstract]   [Full Text] [Related]  

  • 9. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 10. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of microcirculation in patients with diabetic angiopathies].
    Tsiukhno ZI; Tkach FS; Voropaĭ TI
    Probl Endokrinol (Mosk); 1983; 29(5):12-5. PubMed ID: 6647423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of vasodilating drugs in peripheral vascular disease.
    Karpman HL; Okun R
    Geriatrics; 1972 Nov; 27(11):101-7. PubMed ID: 4562846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chelates in the treatment of obliterating arterial diseases. (Preliminary report)].
    Brücknerová O; Tulácek J; Krojzl O
    Vnitr Lek; 1968 Sep; 14(9):841-5. PubMed ID: 4971419
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of the mandelic ester of 3,5,5-trimethyl-cyclohexanol (Cyclospasmol) on blood flow potentials in peripheral obstructive arteriopathies].
    Russo A; Azzolina P; Biondi M; Montemagno S; Giovinetto A
    Minerva Med; 1969 Aug; 60(69):3110-6. PubMed ID: 5824709
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 19. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P; Martinelli M; De Gregorio M
    Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.